Clinical Trial Update: Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder [Phase 4]

View source ↗

Summary

Phase 4 trial reports on the safety and efficacy of oxybutynin topical gel in children with neurogenic bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Overactive Bladder

Drugs mentioned

• Oxybutynin Topical Gel (oxybutynin topical gel)

Snippet

Sponsor: AbbVie | Conditions: Overactive Detrusor, Neurogenic Bladder | Phase 4 | Status: COMPLETED | Results posted: 2024-09-04